EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Apoptotic signaling by TNFR1 is inhibited by the α2-6 sialylation, but not α2-3 sialylation, of the TNFR1 N-glycans

Jihye Hwang, Tejeshwar C Rao, Jiahui Tao, Bingdong Sha, Yoshiki Narimatsu, Henrik Clausen, Alexa L Mattheyses, Susan L Bellis

Journal of Biological Chemistry · 2025-01 · 301 (1) · 108043

DOI: 10.1016/j.jbc.2024.108043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025-01. Verfasst von Jihye Hwang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Apoptosis, Receptors, Tumor Necrosis Factor, Type I, Signal Transduction, Polysaccharides. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The TNF-TNFR1 signaling pathway plays a pivotal role in regulating the balance between cell survival and cell death. Upon binding to TNF, plasma membrane-localized TNFR1 initiates survival signaling, whereas TNFR1 internalization promotes caspase-mediated apoptosis. We previously reported that the α2-6 sialylation of TNFR1 by the tumor-associated sialyltransferase ST6GAL1 diverts signaling toward survival by inhibiting TNFR1 internalization. In the current investigation, we interrogated the mechanisms underlying sialylation-dependent regulation of TNFR1 and uncovered a novel role for α2-6 sialylation, but not α2-3 sialylation, in mediating apoptosis-resistance. Our studies utilized HEK293 cells with deletion of sialyltransferases that modify N-glycans with either α2-3-linked sialic acids (ST3GAL3/4/6) or α2-6-linked sialic acids (ST6GAL1/2). Additionally, ST6GAL1 was re-expressed in cells with ST6GAL1/2 deletion to restore α2-6 sialylation. Using total internal reflection fluorescence (TIRF) microscopy and BS3 cross-linking, we determined that, under basal conditions, cells expressing TNFR1 devoid of α2-6 sialylation displayed enhanced TNFR1 oligomerization, an event that poises cells for activation by TNF. Moreover, upon stimulation with TNF, greater internalization of TNFR1 was observed via time-lapse TIRF and flow cytometry, and this correlated with increased caspase-dependent apoptosis. These effects were reversed by ST6GAL1 re-expression. Conversely, eliminating α2-3 sialylation did not significantly alter TNFR1 clustering, internalization or apoptosis. We also evaluated the Fas receptor, given its structural similarity to TNFR1. As with TNFR1, α2-6 sialylation had a selective effect in protecting cells against Fas-mediated apoptosis. These results collectively suggest that ST6GAL1 may serve a unique function in shielding cancer cells from apoptotic stimuli within the tumor microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisReceptors, Tumor Necrosis Factor, Type ISignal TransductionPolysaccharidesN-Acetylneuraminic AcidHumansSialyltransferasesHEK293 CellsTumor Necrosis Factor-alphabeta-D-Galactoside alpha 2-6-SialyltransferaseAntigens, CD

Stichwörter der Autor:innen

FasST6GAL1TNFR1apoptosiscancerdeath receptorsglycosylationsialic acid

Substanzen

Receptors, Tumor Necrosis Factor, Type ISialyltransferasesST6GAL1 protein, humanPolysaccharidesN-Acetylneuraminic AcidTumor Necrosis Factor-alphabeta-D-Galactoside alpha 2-6-SialyltransferaseAntigens, CD

Autor:innen und Institutionen

  • Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA. Electronic address: mattheyses@uab.edu.
  • Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA. Electronic address: bellis@uab.edu.

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • National Science Foundation
  • Danish National Research Foundation
  • National Cancer Institute
  • Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Hwang, J., Rao, T. C., Tao, J., Sha, B., Narimatsu, Y., Clausen, H., Mattheyses, A. L., & Bellis, S. L. (2025). Apoptotic signaling by TNFR1 is inhibited by the α2-6 sialylation, but not α2-3 sialylation, of the TNFR1 N-glycans. Journal of Biological Chemistry, 301(1), 108043. https://doi.org/10.1016/j.jbc.2024.108043

Vancouver

Hwang J, Rao TC, Tao J, Sha B, Narimatsu Y, Clausen H, et al. Apoptotic signaling by TNFR1 is inhibited by the α2-6 sialylation, but not α2-3 sialylation, of the TNFR1 N-glycans. Journal of Biological Chemistry. 2025;301(1):108043. doi:10.1016/j.jbc.2024.108043

BibTeX
@article{Hwang2025,
  author = {Hwang, Jihye and Rao, Tejeshwar C and Tao, Jiahui and Sha, Bingdong and Narimatsu, Yoshiki and Clausen, Henrik and Mattheyses, Alexa L and Bellis, Susan L},
  title = {Apoptotic signaling by TNFR1 is inhibited by the α2-6 sialylation, but not α2-3 sialylation, of the TNFR1 N-glycans},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  volume = {301},
  number = {1},
  pages = {108043},
  doi = {10.1016/j.jbc.2024.108043}
}
Kostenlos starten →